NCT05237947 2026-03-19PRISMANational Cancer Institute (NCI)Phase 4 Active not recruiting5,000 enrolled
NCT04206813 2026-01-27An Exploratory Open-Label Clinical Trial Evaluating the Immunogenicity of the 9-valent 2-dose HPV Vaccination RegimenBoston Medical CenterPhase 4 Active not recruiting352 enrolled
NCT03023631 2025-11-18Gardasil 9 Vaccine in Preventing HPV Infection in Patients With Hematologic Malignancies Undergoing Donor Stem Cell TransplantM.D. Anderson Cancer CenterPhase 4 Active not recruiting48 enrolled
NCT03180034 2025-09-04ESCUDDONational Cancer Institute (NCI)Phase 4 Active not recruiting27,945 enrolled
NCT04270773 2024-07-109-VPH-MVIHUniversity Hospital Virgen de las NievesPhase 4 Active not recruiting158 enrolled